Skip to content
Biodatica
Start free

Zhejiang Kanova Biopharmaceutical Co., LTD

Hangzhou, Zhejiang

OncologyPhase I
Compare Sign in to watch

What changed

Study registered, no phase assigned: Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

1w agoTrial registeredJul 8, 2026Source filing (opens the source filing in a new tab)

Momentum

84no change

Momentum 84 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase I

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,208 pre-ticker oncology companies at Phase I

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Apr 13, 2026

    Liver Cancer (Primary and Metastatic), Liver Ablation · RECRUITING · sponsor: Fudan University · Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

    ClinicalTrials.gov · NCT07459309 (opens the source filing in a new tab)

  2. Trial

    NA registered

    Jun 1, 2025

    Pain · RECRUITING · sponsor: The University of Texas Health Science Center, Houston · Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain

    ClinicalTrials.gov · NCT06968689 (opens the source filing in a new tab)

  3. Trial

    Study registered

    Nov 13, 2024

    Acute Pancreatitis (AP), Hypertriglyceridemia Acute Pancreatitis · ENROLLING_BY_INVITATION · sponsor: Peking Union Medical College Hospital · Multicenter Prospective Cohort Study of Hypertriglyceridemia Acute Pancreatitis

    ClinicalTrials.gov · NCT06976099 (opens the source filing in a new tab)

  4. Trial

    PHASE1 registered

    Dec 26, 2023

    Asthma Patients · COMPLETED · sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD · A Single-Arm Phase Ic Clinical Study of XKH001 Injection in Patients With Allergic Asthma After Multiple Doses

    ClinicalTrials.gov · NCT07070297 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources